Rapid rate of peripheral blood blast clearance accurately predicts complete remission in acute myeloid leukemia

Vainstein, V; Buckley, S A; Shukron, O; Estey, E H; Abkowitz, J L; Wood, B L; Walter, R B
March 2014
Leukemia (08876924);Mar2014, Vol. 28 Issue 3, p713
Academic Journal
The article presents a study which examines remission prediction in acute myeloid leukemia (AML) with rapid rate of peripheral blood blast (PBB) clearance. The study revealed that 82 patients obtained complete remission (CR) after chemotherapy's single course in 106 patients where PBB kinetics were modeled. It showed that rapid PBB clearance, as indicated by a big decay constant (x), was highly predictive of CR achievement, having x = 1.18 optimal cutoff.


Related Articles

  • Selection of Elderly Acute Myeloid Leukemia Patients for Intensive Chemotherapy: Effectiveness of Intensive Chemotherapy and Subgroup Analysis. Kim, Dae Sik; Kang, Ka Won; Yu, Eun Sang; Kim, Hong Jun; Kim, Jung Sun; Lee, Se Ryeon; Park, Yong; Sung, Hwa Jung; Yoon, Soo Young; Choi, Chul Won; Kim, Byung Soo // Acta Haematologica;Apr2015, Vol. 133 Issue 3, p300 

    Background: Despite the advances in acute myeloid leukemia (AML) treatment, the prognosis of elderly patients remains poor and no definitive treatment guideline has been established. In the present study, we aimed to evaluate the effectiveness of intensive chemotherapy in elderly AML patients...

  • Excavated pneumonia: an unusual suspect. Bellesoeur, Audrey; Chalumeau-Lemoine, Ludivine; Blot, François // Intensive Care Medicine;Jul2013, Vol. 39 Issue 7, p1318 

    The article presents a medical case of a 23-year-old man who was treated with induction chemotherapy and antimicrobial prophylaxis with broad spectrum antibiotherapy and caspofungin after he was diagnosed with acute myeloid leukaemia.

  • Invasive Coinfection with Aspergillus and Mucor in a Patient with Acute Myeloid Leukemia. Bergantim, Rui; Rios, Elisabete; Trigo, Fernanda; Guimarães, Jose // Clinical Drug Investigation;Feb2013 Supplement, Vol. 33, p51 

    The authors report the case of a 58-year-old female patient with a life-threatening invasive fungal disease caused by a coinfection of Aspergillus and Mucor species that occurred during induction and consolidation chemotherapy for an acute myeloid leukemia. The disease was successfully treated...

  • Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making. Ferrara, F; Barosi, G; Venditti, A; Angelucci, E; Gobbi, M; Pane, F; Tosi, P; Zinzani, P; Tura, S // Leukemia (08876924);May2013, Vol. 27 Issue 5, p997 

    The authors reflect on the aspects of not being suitable for non-intensive and intensive therapy in patients with acute myeloid leukemia (AML). They say that they recruited experts in AML to come up with a concensus for therapy decision making. They used an analytic hierarchy process-based...

  • Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients. Wang, Jing-Han; Guo, Qi; Ma, Zhi-Xin; Ma, Qiu-Ling; Yu, Meng-Xia; Yin, Xiu-Feng; Lu, Sha-Sha; Xie, Hong-Qiong; Jiang, Yue-Hong; Shen, Dan; Ma, Li-Ya; Shi, Hui; Yu, Wen-Juan; Lou, Ye-Jiang; Li, Ying; Yang, Min; Xu, Gai-Xiang; Mao, Li-Ping; Li, Jian-Hu; Wang, Huan-Ping // PLoS ONE;10/14/2015, Vol. 10 Issue 10, p1 

    The effect of time from diagnosis to treatment (TDT) on overall survival of patients with acute myeloid leukemia (AML) remains obscure. Furthermore, whether chemotherapy delay impacts overall survival (OS) of patients with a special molecular subtype has not been investigated. Here, we enrolled...

  • Cell Signaling-Based Classifier Predicts Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia. Cesano, Alessandra; Willman, Cheryl L.; Kopecky, Kenneth J.; Gayko, Urte; Putta, Santosh; Louie, Brent; Westfall, Matt; Purvis, Norman; Spellmeyer, David C.; Marimpietri, Carol; Cohen, Aileen C.; Hackett, James; Shi, Jing; Walker, Michael G.; Sun, Zhuoxin; Paietta, Elisabeth; Tallman, Martin S.; Cripe, Larry D.; Atwater, Susan; Appelbaum, Frederick R. // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Single-cell network profiling (SCNP) data generated from multi-parametric flow cytometry analysis of bone marrow (BM) and peripheral blood (PB) samples collected from patients >55 years old with non-M3 AML were used to train and validate a diagnostic classifier (DXSCNP) for predicting response...

  • High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia.  // New England Journal of Medicine;3/25/2010, Vol. 362 Issue 12, p1155 

    A correction to the article "High-Dose Daunorubicin in Older Patients With Acute Myeloid Leukemia" that was published in the September 24, 2009 issue is presented.

  • NPM1 mutations predicted favorable outcome for older patients with AML.  // Hem/Onc Today;1/25/2010, Vol. 11 Issue 2, p43 

    The article focuses on a study which found that older patients with cytogenetically normal acute myeloid leukemia and NPM1 mutations, particularly those aged 70 years or older, had more favorable outcomes than patients with wild-type NPM1.

  • Acute Leukemia.  // Current Medical Literature: Leukemia & Lymphoma;2013, Vol. 21 Issue 4, p119 

    A review of the article "Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study," by A. Shah and colleagues, which appeared in the periodical "British Journal of Haematology" in the 2013 issue, is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics